New pill shows promise for Hard-to-Treat leukemia patients
Disease control
Not yet recruiting
This study tests a drug called ziftomenib for adults with a specific genetic type of acute myeloid leukemia (AML) who are not healthy enough for standard chemotherapy. The drug blocks a protein called menin that helps cancer cells grow. The goal is to see if it can control the le…
Phase: PHASE2 • Sponsor: Uma Borate • Aim: Disease control
Last updated May 17, 2026 08:14 UTC